- Report
- November 2024
- 120 Pages
Global
From €5196EUR$5,950USD£4,514GBP
- Report
- August 2025
- 187 Pages
Global
From €3096EUR$3,545USD£2,690GBP
€3440EUR$3,939USD£2,988GBP
- Report
- August 2025
- 188 Pages
Global
From €3096EUR$3,545USD£2,690GBP
€3440EUR$3,939USD£2,988GBP
- Report
- September 2025
- 250 Pages
Global
From €3921EUR$4,490USD£3,406GBP
- Report
- January 2025
- 180 Pages
Global
From €3930EUR$4,500USD£3,414GBP
- Clinical Trials
- April 2025
- 110 Pages
Global
From €1747EUR$2,000USD£1,517GBP
- Report
- September 2025
- 287 Pages
Global
From €5109EUR$5,850USD£4,438GBP
- Report
- January 2025
- 200 Pages
Global
From €2183EUR$2,500USD£1,897GBP
- Report
- March 2025
- 81 Pages
Global
From €3500EUR$4,293USD£3,147GBP
- Report
- March 2025
- 199 Pages
Global
From €4362EUR$4,995USD£3,790GBP
- Report
- August 2025
- 198 Pages
Global
From €3096EUR$3,545USD£2,690GBP
€3440EUR$3,939USD£2,988GBP
- Drug Pipelines
- June 2025
- 200 Pages
Global
From €2436EUR$2,789USD£2,116GBP
- Report
- August 2025
- 188 Pages
Global
From €3096EUR$3,545USD£2,690GBP
€3440EUR$3,939USD£2,988GBP
- Report
- August 2025
- 190 Pages
Global
From €3096EUR$3,545USD£2,690GBP
€3440EUR$3,939USD£2,988GBP
- Report
- September 2025
- 250 Pages
Global
From €3921EUR$4,490USD£3,406GBP
- Report
- January 2025
- 175 Pages
Global
From €3921EUR$4,490USD£3,406GBP
- Report
- August 2025
- 193 Pages
Global
From €3096EUR$3,545USD£2,690GBP
€3440EUR$3,939USD£2,988GBP
- Report
- September 2025
- 322 Pages
Global
From €5109EUR$5,850USD£4,438GBP
- Report
- February 2024
- 122 Pages
Global
From €2611EUR$2,990USD£2,268GBP
- Report
- February 2021
- 345 Pages
Global
From €3275EUR$3,750USD£2,845GBP

The Erectile Dysfunction Drug market is a subset of the Sexual and Reproductive Health Drugs market. These drugs are used to treat erectile dysfunction, a condition in which a man is unable to achieve or maintain an erection sufficient for sexual intercourse. Common treatments include phosphodiesterase type 5 inhibitors, such as sildenafil, tadalafil, and vardenafil, as well as testosterone replacement therapy. These drugs are typically prescribed by a doctor and can be taken orally or injected directly into the penis.
The Erectile Dysfunction Drug market is highly competitive, with many companies offering a variety of treatments. Some of the major players in the market include Pfizer, Eli Lilly, Bayer, Merck, and GlaxoSmithKline. Other companies include Teva Pharmaceuticals, Sun Pharmaceuticals, and Cipla. Show Less Read more